US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 21.300
  • +0.380+1.82%
Close Feb 14 16:00 ET
  • 21.110
  • -0.190-0.89%
Pre 04:51 ET
13.53BMarket Cap12.49P/E (TTM)

Genmab Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
30.67%21.53B
35.34%6.44B
17.57%5.54B
29.58%5.4B
46.19%4.14B
13.57%16.47B
-7.36%4.76B
15.29%4.71B
31.85%4.17B
33.74%2.83B
Operating revenue
31.52%20.53B
39.79%5.45B
17.57%5.54B
29.58%5.4B
49.79%3.86B
14.05%15.61B
-20.72%3.9B
24.66%4.71B
31.85%4.17B
29.99%2.58B
Cost of revenue
335.84%985M
167.46%337M
245.57%273M
804.76%190M
185M
226M
126M
79M
21M
0
Gross profit
26.42%20.54B
31.75%6.1B
13.68%5.27B
25.65%5.21B
39.66%3.96B
12.02%16.25B
-9.81%4.63B
13.36%4.63B
4.15B
2.83B
Operating expense
23.89%13.54B
35.77%3.91B
6.78%3.15B
26.72%3.4B
30.62%3.16B
32.64%10.93B
12.49%2.88B
36.73%2.95B
39.95%2.68B
50.59%2.42B
Selling and administrative expenses
14.95%3.79B
33.73%1.25B
0.58%865M
8.10%894M
26.78%857M
23.21%3.3B
1.41%934M
28.36%860M
30.65%827M
49.56%676M
Research and development costs
27.76%9.75B
36.76%2.66B
9.34%2.28B
35.02%2.5B
32.11%2.3B
37.18%7.63B
18.71%1.95B
40.51%2.09B
44.54%1.85B
51.00%1.74B
Operating profit
31.61%7B
25.13%2.19B
25.76%2.12B
23.71%1.82B
92.09%801M
-15.09%5.32B
-32.00%1.75B
-12.74%1.69B
17.72%1.47B
-18.87%417M
Net non-operating interest income expense
-4.06%875M
-41.18%170M
-38.72%144M
35.15%273M
54.84%288M
200.99%912M
114.07%289M
158.24%235M
348.89%202M
481.25%186M
Non-operating interest income
5.96%995M
-16.10%224M
-33.61%162M
28.63%292M
53.65%295M
189.81%939M
90.71%267M
151.55%244M
345.10%227M
433.33%192M
Non-operating interest expense
344.44%120M
345.45%54M
100.00%18M
-24.00%19M
16.67%7M
28.57%27M
-540.00%-22M
50.00%9M
316.67%25M
50.00%6M
Other net income (expense)
315.77%1.29B
220.14%1.24B
-172.53%-544M
58.33%38M
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
Gain on sale of security
366.11%1.59B
223.14%1.27B
-170.27%-527M
791.67%214M
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
Special income (charges)
---300M
---31M
---17M
---176M
----
----
----
--0
--0
----
-Less:Restructuring and merger&acquisition
--300M
--31M
--17M
--176M
----
----
----
--0
--0
----
Income before tax
62.57%9.16B
257.70%3.6B
-35.62%1.72B
25.56%2.13B
545.11%1.72B
-18.83%5.64B
76.05%1.01B
-18.40%2.67B
-31.94%1.69B
-56.54%266M
Income tax
2.72%1.32B
-179.93%-243M
-19.96%453M
100.28%719M
598.21%391M
-13.93%1.29B
424.14%304M
-17.97%566M
-39.97%359M
-61.90%56M
Net income
80.24%7.84B
446.94%3.85B
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
Net income continuous Operations
80.24%7.84B
446.94%3.85B
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
Minority interest income
Net income attributable to the parent company
80.24%7.84B
446.94%3.85B
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.24%7.84B
446.94%3.85B
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
Basic earnings per share
83.39%12.221
458.74%6.012
-38.11%1.994
6.79%2.185
532.09%2.029
-20.08%6.664
36.20%1.076
-18.53%3.222
-29.13%2.046
-54.79%0.321
Diluted earnings per share
83.82%12.136
461.58%5.964
-37.98%1.981
7.00%2.17
532.60%2.018
-20.06%6.602
36.86%1.062
-18.46%3.194
-29.24%2.028
-54.75%0.319
Dividend per share
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 30.67%21.53B35.34%6.44B17.57%5.54B29.58%5.4B46.19%4.14B13.57%16.47B-7.36%4.76B15.29%4.71B31.85%4.17B33.74%2.83B
Operating revenue 31.52%20.53B39.79%5.45B17.57%5.54B29.58%5.4B49.79%3.86B14.05%15.61B-20.72%3.9B24.66%4.71B31.85%4.17B29.99%2.58B
Cost of revenue 335.84%985M167.46%337M245.57%273M804.76%190M185M226M126M79M21M0
Gross profit 26.42%20.54B31.75%6.1B13.68%5.27B25.65%5.21B39.66%3.96B12.02%16.25B-9.81%4.63B13.36%4.63B4.15B2.83B
Operating expense 23.89%13.54B35.77%3.91B6.78%3.15B26.72%3.4B30.62%3.16B32.64%10.93B12.49%2.88B36.73%2.95B39.95%2.68B50.59%2.42B
Selling and administrative expenses 14.95%3.79B33.73%1.25B0.58%865M8.10%894M26.78%857M23.21%3.3B1.41%934M28.36%860M30.65%827M49.56%676M
Research and development costs 27.76%9.75B36.76%2.66B9.34%2.28B35.02%2.5B32.11%2.3B37.18%7.63B18.71%1.95B40.51%2.09B44.54%1.85B51.00%1.74B
Operating profit 31.61%7B25.13%2.19B25.76%2.12B23.71%1.82B92.09%801M-15.09%5.32B-32.00%1.75B-12.74%1.69B17.72%1.47B-18.87%417M
Net non-operating interest income expense -4.06%875M-41.18%170M-38.72%144M35.15%273M54.84%288M200.99%912M114.07%289M158.24%235M348.89%202M481.25%186M
Non-operating interest income 5.96%995M-16.10%224M-33.61%162M28.63%292M53.65%295M189.81%939M90.71%267M151.55%244M345.10%227M433.33%192M
Non-operating interest expense 344.44%120M345.45%54M100.00%18M-24.00%19M16.67%7M28.57%27M-540.00%-22M50.00%9M316.67%25M50.00%6M
Other net income (expense) 315.77%1.29B220.14%1.24B-172.53%-544M58.33%38M286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M
Gain on sale of security 366.11%1.59B223.14%1.27B-170.27%-527M791.67%214M286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M
Special income (charges) ---300M---31M---17M---176M--------------0--0----
-Less:Restructuring and merger&acquisition --300M--31M--17M--176M--------------0--0----
Income before tax 62.57%9.16B257.70%3.6B-35.62%1.72B25.56%2.13B545.11%1.72B-18.83%5.64B76.05%1.01B-18.40%2.67B-31.94%1.69B-56.54%266M
Income tax 2.72%1.32B-179.93%-243M-19.96%453M100.28%719M598.21%391M-13.93%1.29B424.14%304M-17.97%566M-39.97%359M-61.90%56M
Net income 80.24%7.84B446.94%3.85B-39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M
Net income continuous Operations 80.24%7.84B446.94%3.85B-39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M
Minority interest income
Net income attributable to the parent company 80.24%7.84B446.94%3.85B-39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.24%7.84B446.94%3.85B-39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M
Basic earnings per share 83.39%12.221458.74%6.012-38.11%1.9946.79%2.185532.09%2.029-20.08%6.66436.20%1.076-18.53%3.222-29.13%2.046-54.79%0.321
Diluted earnings per share 83.82%12.136461.58%5.964-37.98%1.9817.00%2.17532.60%2.018-20.06%6.60236.86%1.062-18.46%3.194-29.24%2.028-54.75%0.319
Dividend per share
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.